Exact peptide identities attached to retained registry observations carrying this condition label.
Official registry condition
Septic Shock peptide trials
6 selected ClinicalTrials.gov records carrying the official condition label Septic Shock. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
6 selected records.
3 profiles.
2016–2026 in selected records.
Indication intelligence
Selected evidence landscape
Phase labels copied from the retained ClinicalTrials.gov versions.
Overall statuses at each retained observation, not necessarily current today.
Across the connected peptide profiles, PeptideScanner also carries 90 selected PubMed records and 15 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Septic Shock unless their own cited source says so.
Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
ClinicalTrials.gov record NCT00628160
PeptideScanner retained ClinicalTrials.gov record NCT00628160 at 2026-11-15T21:47:40.408Z. Its registry update date was 2016-02-24, and PeptideScanner's reviewed identity mapping was terlipressin.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- February 24, 2016
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT01718613
PeptideScanner retained ClinicalTrials.gov record NCT01718613 at 2026-11-15T22:08:31.832Z. Its registry update date was 2018-05-18, and PeptideScanner's reviewed identity mapping was vasopressin.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- May 18, 2018
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT05506319
PeptideScanner retained ClinicalTrials.gov record NCT05506319 at 2026-11-15T22:08:31.832Z. Its registry update date was 2025-03-14, and PeptideScanner's reviewed identity mapping was vasopressin.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- March 14, 2025
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Thymosin alpha-1 · 2026-11-06
ClinicalTrials.gov record NCT07922954
Active, not recruiting at the retained observation.
Open attributed record →Vasopressin · 2026-08-31
ClinicalTrials.gov record NCT06709573
Recruiting at the retained observation.
Open attributed record →Vasopressin · 2026-08-03
ClinicalTrials.gov record NCT06217562
Completed at the retained observation.
Open attributed record →Vasopressin · 2025-03-14
ClinicalTrials.gov record NCT05506319
Completed at the retained observation.
Open attributed record →Vasopressin · 2018-05-18
ClinicalTrials.gov record NCT01718613
Completed at the retained observation.
Open attributed record →Terlipressin · 2016-02-24
ClinicalTrials.gov record NCT00628160
Completed at the retained observation.
Open attributed record →